FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2027156933> ?p ?o ?g. }

• W2027156933 endingPage "2347" @default.
• W2027156933 startingPage "2342" @default.
• W2027156933 abstract "Knottins are small constrained polypeptides that share a common disulfide-bonded framework and a triple-stranded β-sheet fold. Previously, directed evolution of the Ecballium elaterium trypsin inhibitor (EETI-II) knottin led to the identification of a mutant that bound to tumor-specific αvβ3 and αvβ5 integrin receptors with low nanomolar affinity. The objective of this study was to prepare and evaluate a radiofluorinated version of this knottin (termed 2.5D) for microPET imaging of integrin positive tumors in living subjects. Knottin peptide 2.5D was prepared by solid-phase synthesis and folded in vitro, and its free N-terminal amine was reacted with N-succinimidyl-4-18/19F-fluorobenzoate (18/19F-SFB) to produce the fluorinated peptide 18/19F-FB-2.5D. The binding affinities of unlabeled knottin peptide 2.5D and 19F-FB-2.5D to U87MG glioblastoma cells were measured by competition binding assay using 125I-labeled echistatin. It was found that unlabeled 2.5D and 19F-FB-2.5D competed with 125I-echistatin for binding to cell surface integrins with IC50 values of 20.3 ± 7.3 and 13.2 ± 5.4 nM, respectively. Radiosynthesis of 18F-FB-2.5D resulted in a product with high specific activity (ca. 100 GBq/μmol). Next, biodistribution and positron emission tomography (PET) imaging studies were performed to evaluate the in vivo behavior of 18F-FB-2.5D. Approximately 3.7 MBq 18F-FB-2.5D was injected into U87MG tumor-bearing mice via the tail vein. Biodistribution studies demonstrated that 18F-FB-2.5D had moderate tumor uptake at 0.5 h post injection, and coinjection of a large excess of the unlabeled peptidomimetic c(RGDyK) as a blocking agent significantly reduced tumor uptake (1.90 ± 1.15 vs 0.57 ± 0.14%ID/g, 70% inhibition, P < 0.05). In vivo microPET imaging showed that 18F-FB-2.5D rapidly accumulated in the tumor and quickly cleared from the blood through the kidneys, allowing excellent tumor-to-normal tissue contrast to be obtained. Collectively, 18F-FB-2.5D allows integrin-specific PET imaging of U87MG tumors with good contrast and further demonstrates that knottins are excellent peptide scaffolds for development of PET probes with potential for clinical translation." @default.
• W2027156933 created "2016-06-24" @default.
• W2027156933 creator A5019955301 @default.
• W2027156933 creator A5031871633 @default.
• W2027156933 creator A5053731056 @default.
• W2027156933 creator A5058204963 @default.
• W2027156933 creator A5059512294 @default.
• W2027156933 creator A5061271062 @default.
• W2027156933 creator A5067589644 @default.
• W2027156933 creator A5075963891 @default.
• W2027156933 date "2009-11-12" @default.
• W2027156933 modified "2023-09-24" @default.
• W2027156933 title "An Engineered Knottin Peptide Labeled with ¹⁸F for PET Imaging of Integrin Expression" @default.
• W2027156933 cites W1965040263 @default.
• W2027156933 cites W1971145143 @default.
• W2027156933 cites W1973993174 @default.
• W2027156933 cites W1976595458 @default.
• W2027156933 cites W1978035213 @default.
• W2027156933 cites W1986676428 @default.
• W2027156933 cites W1998003752 @default.
• W2027156933 cites W2001606031 @default.
• W2027156933 cites W2023703420 @default.
• W2027156933 cites W2030476352 @default.
• W2027156933 cites W2042979331 @default.
• W2027156933 cites W2057305507 @default.
• W2027156933 cites W2057520802 @default.
• W2027156933 cites W2071667499 @default.
• W2027156933 cites W2097776311 @default.
• W2027156933 cites W2102645291 @default.
• W2027156933 cites W2108796583 @default.
• W2027156933 cites W2116667571 @default.
• W2027156933 cites W2124114323 @default.
• W2027156933 cites W2131443651 @default.
• W2027156933 cites W2155707671 @default.
• W2027156933 doi "https://doi.org/10.1021/bc900361g" @default.
• W2027156933 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2804269" @default.
• W2027156933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19908826" @default.
• W2027156933 hasPublicationYear "2009" @default.
• W2027156933 type Work @default.
• W2027156933 sameAs 2027156933 @default.
• W2027156933 citedByCount "44" @default.
• W2027156933 countsByYear W20271569332012 @default.
• W2027156933 countsByYear W20271569332013 @default.
• W2027156933 countsByYear W20271569332014 @default.
• W2027156933 countsByYear W20271569332015 @default.
• W2027156933 countsByYear W20271569332016 @default.
• W2027156933 countsByYear W20271569332017 @default.
• W2027156933 countsByYear W20271569332018 @default.
• W2027156933 countsByYear W20271569332019 @default.
• W2027156933 countsByYear W20271569332020 @default.
• W2027156933 countsByYear W20271569332021 @default.
• W2027156933 countsByYear W20271569332022 @default.
• W2027156933 crossrefType "journal-article" @default.
• W2027156933 hasAuthorship W2027156933A5019955301 @default.
• W2027156933 hasAuthorship W2027156933A5031871633 @default.
• W2027156933 hasAuthorship W2027156933A5053731056 @default.
• W2027156933 hasAuthorship W2027156933A5058204963 @default.
• W2027156933 hasAuthorship W2027156933A5059512294 @default.
• W2027156933 hasAuthorship W2027156933A5061271062 @default.
• W2027156933 hasAuthorship W2027156933A5067589644 @default.
• W2027156933 hasAuthorship W2027156933A5075963891 @default.
• W2027156933 hasBestOaLocation W20271569332 @default.
• W2027156933 hasConcept C136339569 @default.
• W2027156933 hasConcept C150903083 @default.
• W2027156933 hasConcept C153911025 @default.
• W2027156933 hasConcept C170493617 @default.
• W2027156933 hasConcept C185592680 @default.
• W2027156933 hasConcept C195687474 @default.
• W2027156933 hasConcept C202751555 @default.
• W2027156933 hasConcept C207001950 @default.
• W2027156933 hasConcept C2775842073 @default.
• W2027156933 hasConcept C2776970183 @default.
• W2027156933 hasConcept C2777807558 @default.
• W2027156933 hasConcept C2779281246 @default.
• W2027156933 hasConcept C2989005 @default.
• W2027156933 hasConcept C55493867 @default.
• W2027156933 hasConcept C71924100 @default.
• W2027156933 hasConcept C86803240 @default.
• W2027156933 hasConceptScore W2027156933C136339569 @default.
• W2027156933 hasConceptScore W2027156933C150903083 @default.
• W2027156933 hasConceptScore W2027156933C153911025 @default.
• W2027156933 hasConceptScore W2027156933C170493617 @default.
• W2027156933 hasConceptScore W2027156933C185592680 @default.
• W2027156933 hasConceptScore W2027156933C195687474 @default.
• W2027156933 hasConceptScore W2027156933C202751555 @default.
• W2027156933 hasConceptScore W2027156933C207001950 @default.
• W2027156933 hasConceptScore W2027156933C2775842073 @default.
• W2027156933 hasConceptScore W2027156933C2776970183 @default.
• W2027156933 hasConceptScore W2027156933C2777807558 @default.
• W2027156933 hasConceptScore W2027156933C2779281246 @default.
• W2027156933 hasConceptScore W2027156933C2989005 @default.
• W2027156933 hasConceptScore W2027156933C55493867 @default.
• W2027156933 hasConceptScore W2027156933C71924100 @default.
• W2027156933 hasConceptScore W2027156933C86803240 @default.
• W2027156933 hasIssue "12" @default.
• W2027156933 hasLocation W20271569331 @default.
• W2027156933 hasLocation W20271569332 @default.
• W2027156933 hasLocation W20271569333 @default.

• next